5 months into treatment, the shed isn't stopping. Diffuse thinner.
    9/8/2026

    From the encyclopedia
    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    Finasteride →

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Minoxidil (oral) 5mg 5 months
    💊 Finasteride (oral) 1mg 5 months
    the tone is 😐 neutral.

    Other terms

    A 20-year-old is experiencing ongoing hair shedding despite using 5mg minoxidil and 1mg finasteride for five months. They are advised to be patient, as shedding can be part of the treatment process, and to consult a dermatologist for further guidance.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research Hair Loss Treatments for Hair Regrowth in South Africa

      June 2026 in “Figshare”
      This study reviews common hair loss treatments used in South Africa, including minoxidil, topical finasteride, and scalp rollers, detailing their mechanisms, suitable users, side effects, and application needs to help readers make informed choices and create a hair care routine.

      research Hair Loss Treatments for Hair Regrowth in South Africa

      June 2026 in “Figshare”
      In this review, researchers explain various hair loss treatments in South Africa, detailing how they work, who can use them, possible side effects, and guidelines for safe application, helping readers make informed decisions about hair care.

      research Introductory Chapter: Hair Loss

      1 citations , May 2017 in “InTech eBooks”
      The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

      research Common Dermatologic Conditions

      14 citations , April 2014 in “Medical Clinics of North America”
      This review discusses common skin conditions in primary care settings and provides guidance on differential diagnoses and selecting appropriate topical treatments, but it reports no new clinical results.